The Cardiovascular Impact of COVID-19


The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the best medical challenge in decades. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the circulatory system. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia, cardiac injury, fulminant myocarditis, coronary failure, embolism, and disseminated intravascular coagulation (DIC).



 

  • CDC Recognizes COVID Long-Haulers
  • Cardiac Biomarkers
  • Athlete COVID Long-hauler Cardiac Research
  • Congenital heart diseases
  • Myocardial dysfunction
  • Pediatric Multisystem Inflammatory Syndrome
  • SARS-CoV-2

Related Conference of The Cardiovascular Impact of COVID-19

November 13-14, 2025

6th Global Summit on Heart Congress

Paris, France
November 19-20, 2025

7th World Heart Congress

Tokyo, Japan
November 24-25, 2025

36th Annual Cardiologists Conference

Barcelona, Spain
November 27-28, 2025

32nd World Heartcare Summit

Paris, France
January 12-13, 2026

12th International Heart Conference

Dubai, UAE
March 18-19, 2026

15th World Heart Congress

Paris, France
March 23-24, 2026

41st World Cardiology Conference

London, UK
April 08-29, 2026

9th Annual Heart Rhythm Conference

Vienna, Austria
April 13-14, 2026

9th World Heart and Brain Conference

Tokyo, Japan
May 14-15, 2026

5th International Conference on Cardiology

Rome, Italy
May 21-22, 2026

15th World Congress on Cardiology

London, UK
July 29-30, 2026

30th World Cardiology Conference

Paris, France

The Cardiovascular Impact of COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in